HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MicroRNA-sensitive oncolytic measles viruses for cancer-specific vector tropism.

Abstract
Oncolytic measles viruses (MV) derived from the live attenuated vaccine strain have been engineered for increased tumor-cell specificity, and are currently under investigation in clinical trials including a phase I study for glioblastoma multiforme (GBM). Recent preclinical studies have shown that the cellular tropism of several viruses can be controlled by inserting microRNA-target sequences into their genomes, thereby inhibiting spread in tissues expressing cognate microRNAs. Since neuron-specific microRNA-7 is downregulated in gliomas but highly expressed in normal brain tissue, we engineered a microRNA-sensitive virus containing target sites for microRNA-7 in the 3'-untranslated region of the viral fusion gene. In presence of microRNA-7 this modification inhibits translation of envelope proteins, restricts viral spread, and progeny production. Even though highly attenuated in presence of microRNA-7, this virus retained full efficacy against glioblastoma xenografts. Furthermore, microRNA-mediated inhibition protected genetically modified mice susceptible to MV infection from a potentially lethal intracerebral challenge. Importantly, endogenous microRNA-7 expression in primary human brain resections tightly restricted replication and spread of microRNA-sensitive virus. This is proof-of-concept that tropism restriction by tissue-specific microRNAs can be adapted to oncolytic MV to regulate viral replication and gene expression to maximize tumor specificity without compromising oncolytic efficacy.
AuthorsMathias F Leber, Sascha Bossow, Vincent H J Leonard, Karim Zaoui, Christian Grossardt, Marie Frenzke, Tanner Miest, Stefanie Sawall, Roberto Cattaneo, Christof von Kalle, Guy Ungerechts
JournalMolecular therapy : the journal of the American Society of Gene Therapy (Mol Ther) Vol. 19 Issue 6 Pg. 1097-106 (Jun 2011) ISSN: 1525-0024 [Electronic] United States
PMID21468006 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • MicroRNAs
Topics
  • Animals
  • Brain Neoplasms (therapy)
  • Cell Line
  • Cell Line, Tumor
  • Cell Survival (genetics, physiology)
  • Chlorocebus aethiops
  • Female
  • Genetic Vectors (genetics)
  • Glioblastoma (therapy)
  • Glioma (therapy)
  • Humans
  • Immunoblotting
  • In Vitro Techniques
  • Measles virus (genetics, physiology)
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • MicroRNAs (genetics)
  • Oncolytic Virotherapy
  • Oncolytic Viruses (genetics, physiology)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Vero Cells
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: